I get the feeling from some posters that serious talks with
I get the feeling from some posters that serious talks with BP will begin only after P2 data is released. IMO talks started once they signed the CDA and they and mgt have been feeling each other out and communicating heavily and continuously behind the scene as to the science of each drug. Thus, the release of P2 data is the heralding of the last hurrah before a deal, not the opening act. If I am a BP and I know IPIX has other CDA's, I am not going to have sketchy communications with them, I am going to have some one/team talking to them constantly to let IPIX know how serious is my intention to be their primary partner.
Just a gut feeling, but I believe mgt already knows who they want to partner with and who they are going to sign as to partnerships and it isn't going to take that long once final (or possibly even top line for P if it is real strong data) results are published. Certainly not months after results.
I was shocked at the speed of the secondary endpoint data PR for B-OM as I had that expectation schedule for the end of Jan time frame at best and most likely mid-Feb. Then I heard from another board that the CSR (?) final report to FDA to get going on a P3 is possibly going to ready before the end of the month? Way faster than I expected. That just leaves the P top line data which I have been thinking is most likely by mid-March but now I believe that may come a bit quicker than I had thought so anything after mid-Feb wouldn't surprise me.
I knew we had the products, I am amazed at how quickly we are knocking out the requirements for the continuation of the trials. Pretty sure that is due to Dr. B. Worth every penny we are paying him IMO.
4
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Riding the Tactical Communication Wave Alright, here’s something to chew on over your morning coffee. The tactical communication market is projected to balloon from USD 13.14 billion in 2026 to a whopping USD 19.39 billion by 2031. That’s an 8.1% CAGR if you’re keeping track—no small peanuts. So what's driving this surge? It’s all about security, modernization,...
Continue Reading
ELEGOO's 2026 Holiday Strategy: Deep Discounts Welcome to the world of sharp deals and crafty creations as ELEGOO kicks off its Black Friday and Cyber Monday extravaganza. This time, they're slashing prices by up to 54% on their impressive lineup of 3D printers and captivating accessories. Yeah, it's that time of year when wallets might take a hit, but for a good reason....
Continue Reading
Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...
Continue Reading
A Grand Meeting with Serious Stakes The Board at Stora Enso Oyj is calling for an Extraordinary General Meeting (EGM) to tackle something massive—a cross-border partial demerger. Scheduled for December 15, 2026, this big pow-wow will take place in Helsinki, Finland. There’s a boatload of logistics in play, not least because it’s intended to split off their Swedish...
Continue Reading
A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...
Continue Reading
A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...
Continue Reading
Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...
Continue Reading
Another Quarter Under the Belt Just when you think the hospitality industry's running out of steam, Choice Hotels International decides to shake things up. Reporting their third quarter 2026 results, the big picture here demands an attentive eye from investors. In the turbulent world of lodging franchises, NYSE:CHH is making waves, and I mean literal waves, as they surf...
Continue Reading
Allegiant Airlines and UNLV: A Unique Collaboration The world of airline customer service is about to get a shakeup, thanks to a new collaboration between Allegiant Airlines and the University of Nevada, Las Vegas' renowned William F. Harrah College of Hospitality. It's a partnership that aims to bring a new level of service to the skies, guided by some of the best minds...
Continue Reading
Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...
Continue Reading
Top 5 Most Recently Viewed Articles
Revolutionizing Pickleball Play in Cold Weather Inventors around the country are constantly looking for ways to improve athletic experiences. One recent innovation is the PICKLE BALL WARMER, a product that aims to enhance the game of pickleball. Pickleball players know how important it is to have equipment that works perfectly, especially when temperatures drop. With this...
Continue Reading
UnitedHealth's Fourth Quarter Earnings Analysis Recently, UnitedHealth (NYSE: UNH) delivered its fourth-quarter earnings report, revealing an EPS of $6.81, surpassing the analyst expectation of $6.74 by $0.07. However, on the revenue front, the company reported $100.8 billion, slightly lower than the anticipated $101.61 billion. This mixed result has analysts abuzz...
Continue Reading
Preparing for Earnings: Ramaco Resources' Insights Ramaco Resources (NASDAQ: METC) is gearing up for its upcoming quarterly earnings announcement. Investors are advised to stay tuned for key insights and takeaways from the release. This earnings season holds particular significance for the company, and there are several factors to consider ahead of the report. Analyst...
Continue Reading
Hormel Foods Honors 2024 Scholarship Winners Hormel Foods Corporation, a distinguished player in the global food industry, takes pride in announcing the latest class of Hormel Heroes Scholarship recipients. This initiative spotlights the achievements of two exceptional students, both with military backgrounds, who are honored with $10,000 scholarships. Empowering Futures...
Continue Reading
Growth of the Global Orthopedic Biomaterials Market The Global Orthopedic Biomaterials Market is set to witness significant growth, with projections indicating an increase from USD 19.50 billion in 2023 to USD 51.50 billion by 2033. This remarkable growth is expected to occur at a compound annual growth rate (CAGR) of 10.20% throughout the forecast period. Understanding...
Continue Reading